70
REFERENFECES
Anand, P., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B. & Aggarwal, B. B. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25, 2097-116.
Agarwal, S., Tafel, A. A. & Kanaar, R. (2006). DNA double-strand break repair and chromosome translocations. DNA Repair (Amst) 5, 1075-81.
Albrektsen, G., Heuch, I., Thoresen, S. & Kvale, G. (2006). Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer 119, 1468-74.
Alter, B. P. (2003). Cancer in Fanconi anemia, 1927-2001. Cancer 97, 425-40.
Baer, R. & Ludwig, T. (2002). The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr Opin Genet Dev 12, 86-91.
Baldeyron, C., Jacquemin, E., Smith, J., Jacquemont, C., De Oliveira, I., Gad, S., Feunteun, J., Stoppa-Lyonnet, D. & Papadopoulo, D. (2002). A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene 21, 1401-10.
Benz, C. C. (2008). Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 66, 65-74.
Berstad, P., Ma, H., Bernstein, L. & Ursin, G. (2008). Alcohol intake and breast cancer risk among young women. Breast Cancer Res Treat 108, 113-20.
Bissonauth, V., Shatenstein, B. & Ghadirian, P. (2008). Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview. Cancer Detect Prev 32, 52-64.
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., Greenblatt, J. J., Rosenberg, S. A., Klein, H., Berger, M., Mullen, C. A., Ramsey, W. J., Muul, L., Morgan, R. A. & Anderson, W. F. (1995). T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270, 475-80.
Bouard, D., Alazard-Dany, N. & Cosset, F. L. (2008). Viral vectors: from virology to transgene expression. Br J Pharmacol.
Brody, J. G. & Rudel, R. A. (2003). Environmental pollutants and breast cancer. Environ Health Perspect 111, 1007-19.
Brzovic, P. S., Keeffe, J. R., Nishikawa, H., Miyamoto, K., Fox, D., 3rd, Fukuda, M., Ohta, T. & Klevit, R. (2003). Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci U S A 100, 5646-51.
Burton, E. A., Wechuck, J. B., Wendell, S. K., Goins, W. F., Fink, D. J. & Glorioso, J. C. (2001). Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells 19, 358-77.
71 Caldecott, K. W. (2003). Cell signaling. The BRCT domain: signaling with friends? Science 302,
579-80.
Campos, S. K. & Barry, M. A. (2007). Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther 7, 189-204.
Chang, L. J. & He, J. (2001). Retroviral vectors for gene therapy of AIDS and cancer. Curr Opin Mol Ther 3, 468-75.
Claus, E. B., Risch, N. & Thompson, W. D. (1994). Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73, 643-51.
Condiotti, R., Curran, M. A., Nolan, G. P., Giladi, H., Ketzinel-Gilad, M., Gross, E. & Galun, E. (2004). Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem Biophys Res Commun 320, 998-1006.
Consiglio, A., Quattrini, A., Martino, S., Bensadoun, J. C., Dolcetta, D., Trojani, A., Benaglia, G., Marchesini, S., Cestari, V., Oliverio, A., Bordignon, C. & Naldini, L. (2001). In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med 7, 310-6.
Coura Rdos, S. & Nardi, N. B. (2007). The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J 4, 99.
Cronin, J., Zhang, X. Y. & Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5, 387-98.
Curran, M. A., Kaiser, S. M., Achacoso, P. L. & Nolan, G. P. (2000). Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther 1, 31-8. Davis, H. E., Rosinski, M., Morgan, J. R. & Yarmush, M. L. (2004). Charged polymers modulate
retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J 86, 1234-42.
Davison, A. J., Benko, M. & Harrach, B. (2003). Genetic content and evolution of adenoviruses. J Gen Virol 84, 2895-908.
Deng, C. X. (2006). BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34, 1416-26.
Di Nunzio, F., Piovani, B., Cosset, F. L., Mavilio, F. & Stornaiuolo, A. (2007). Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Hum Gene Ther 18, 811-20.
Domchek, S. M., Friebel, T. M., Neuhausen, S. L., Wagner, T., Evans, G., Isaacs, C., Garber, J. E., Daly, M. B., Eeles, R., Matloff, E., Tomlinson, G. E., Van't Veer, L., Lynch, H. T., Olopade, O. I., Weber, B. L. & Rebbeck, T. R. (2006). Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7, 223-9.
Donello, J. E., Loeb, J. E. & Hope, T. J. (1998). Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72, 5085-92.
Dong, B., Silverman, R. H. & Kandel, E. S. (2008). A natural human retrovirus efficiently complements vectors based on murine leukemia virus. PLoS ONE 3, e3144.
72 ElShamy, W. M. & Livingston, D. M. (2004). Identification of BRCA1-IRIS, a BRCA1 locus product.
Nat Cell Biol 6, 954-67.
Esslinger, C., Chapatte, L., Finke, D., Miconnet, I., Guillaume, P., Levy, F. & MacDonald, H. R. (2003). In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest 111, 1673-81.
Ferretti, G., Felici, A. & Cognetti, F. (2007). The protective side of progesterone. Breast Cancer Res 9, 402.
Figge, M. A. & Blankenship, L. (2004). Missense mutations in the BRCT domain of BRCA-1 from high-risk women frequently perturb strongly hydrophobic amino acids conserved among mammals. Cancer Epidemiol Biomarkers Prev 13, 1037-41.
Filley, C. M. (2005). White matter and behavioral neurology. Ann N Y Acad Sci 1064, 162-83. Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E. & King, M. C.
(1994). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8, 399-404.
Frost, M. H., Schaid, D. J., Sellers, T. A., Slezak, J. M., Arnold, P. G., Woods, J. E., Petty, P. M., Johnson, J. L., Sitta, D. L., McDonnell, S. K., Rummans, T. A., Jenkins, R. B., Sloan, J. A. & Hartmann, L. C. (2000). Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. Jama 284, 319-24.
Gatei, M., Zhou, B. B., Hobson, K., Scott, S., Young, D. & Khanna, K. K. (2001). Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem 276, 17276-80.
Gill, J. K., Press, M. F., Patel, A. V. & Bernstein, L. (2006). Oral contraceptive use and risk of breast carcinoma in situ (United States). Cancer Causes Control 17, 1155-62.
Graham, F. L. & Prevec, L. (1995). Methods for construction of adenovirus vectors. Mol Biotechnol 3, 207-20.
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B. & King, M. C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-9.
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., Frost, M. H. & Jenkins, R. B. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340, 77-84.
Higashimoto, T., Urbinati, F., Perumbeti, A., Jiang, G., Zarzuela, A., Chang, L. J., Kohn, D. B. & Malik, P. (2007). The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Ther 14, 1298-304. Hoeijmakers, J. H. (2001). Genome maintenance mechanisms for preventing cancer. Nature
411, 366-74.
Hoskins, E. E., Gunawardena, R. W., Habash, K. B., Wise-Draper, T. M., Jansen, M., Knudsen, E. S. & Wells, S. I. (2008). Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene 27, 4798-808.
73 Hussein, M. R., Abd-Elwahed, S. R. & Abdulwahed, A. R. (2008). Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Cell Biol Int 32, 698-707.
Jacobson, H. I., Lemanski, N., Narendran, A., Agarwal, A., Bennett, J. A. & Andersen, T. T. (2008). Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk. Adv Exp Med Biol 617, 477-84.
James, C. R., Quinn, J. E., Mullan, P. B., Johnston, P. G. & Harkin, D. P. (2007). BRCA1, a potential predictive biomarker in the treatment of breast cancer. Oncologist 12, 142-50.
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N. & Edwards, B. K. (2004). Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101, 3-27.
Jumppanen, M., Gruvberger-Saal, S., Kauraniemi, P., Tanner, M., Bendahl, P. O., Lundin, M., Krogh, M., Kataja, P., Borg, A., Ferno, M. & Isola, J. (2007). Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Res 9, R16.
Kennedy, R. D., Quinn, J. E., Mullan, P. B., Johnston, P. G. & Harkin, D. P. (2004). The role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst 96, 1659-68. Kim, H., Chen, J. & Yu, X. (2007). Ubiquitin-binding protein RAP80 mediates BRCA1-dependent
DNA damage response. Science 316, 1202-5.
Kim, S. S., Cao, L., Lim, S. C., Li, C., Wang, R. H., Xu, X., Bachelier, R. & Deng, C. X. (2006). Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform. Mol Cell Biol 26, 6983-92.
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E. Y., Palfi, S., Roitberg, B. Z., Brown, W. D., Holden, J. E., Pyzalski, R., Taylor, M. D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. & Aebischer, P. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-73.
Kramer, J. L., Velazquez, I. A., Chen, B. E., Rosenberg, P. S., Struewing, J. P. & Greene, M. H. (2005). Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23, 8629-35. Kyrkanides, S., Miller, J. H. & Federoff, H. J. (2003). Systemic FIV vector administration:
transduction of CNS immune cells and Purkinje neurons. Brain Res Mol Brain Res 119, 1-9.
Laws, S. C., Carey, S. A., Ferrell, J. M., Bodman, G. J. & Cooper, R. L. (2000). Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54, 154-67.
Lin, Y., Kikuchi, S., Tamakoshi, K., Wakai, K., Kondo, T., Niwa, Y., Yatsuya, H., Nishio, K., Suzuki, S., Tokudome, S., Yamamoto, A., Toyoshima, H., Mori, M. & Tamakoshi, A. (2008). Active smoking, passive smoking, and breast cancer risk: findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Epidemiol 18, 77-83.
Lin, Y. L., Noel, D., Mettling, C., Reant, B., Clot, J., Jorgensen, C. & Corbeau, P. (2004). Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritis. Hum Gene Ther 15, 588-96.
74 Loewen, N., Barraza, R., Whitwam, T., Saenz, D. T., Kemler, I. & Poeschla, E. M. (2003). FIV
Vectors. Methods Mol Biol 229, 251-71.
Loewen, N., Leske, D. A., Cameron, J. D., Chen, Y., Whitwam, T., Simari, R. D., Teo, W. L., Fautsch, M. P., Poeschla, E. M. & Holmes, J. M. (2004). Long-term retinal transgene expression with FIV versus adenoviral vectors. Mol Vis 10, 272-80.
Lux, M. P., Fasching, P. A. & Beckmann, M. W. (2006). Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med 84, 16-28.
Matsuno, R. K., Anderson, W. F., Yamamoto, S., Tsukuma, H., Pfeiffer, R. M., Kobayashi, K., Devesa, S. S. & Levine, P. H. (2007). Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomarkers Prev 16, 1437-42.
May, C., Rivella, S., Chadburn, A. & Sadelain, M. (2002). Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene. Blood 99, 1902-8. McCoy, M. L., Mueller, C. R. & Roskelley, C. D. (2003). The role of the breast cancer
susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reprod Biol Endocrinol 1, 72.
Metharom, P., Ellem, K. A. & Wei, M. Q. (2005). Gene Transfer to Dendritic Cells Induced a Protective Immunity against Melanoma. Cell Mol Immunol 2, 281-8.
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W. & et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
Mustafa, F., Ghazawi, A., Jayanth, P., Phillip, P. S., Ali, J. & Rizvi, T. A. (2005). Sequences intervening between the core packaging determinants are dispensable for maintaining the packaging potential and propagation of feline immunodeficiency virus transfer vector RNAs. J Virol 79, 13817-21.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M. & Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-7.
Narod, S. A., Brunet, J. S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S. L., Stoppa-Lyonnet, D., Lerman, C., Pasini, B., de los Rios, P., Weber, B. & Lynch, H. (2000). Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356, 1876-81.
Ngoi, S. M., Chien, A. C. & Lee, C. G. (2004). Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 4, 15-31.
Obermiller, P. S., Tait, D. L. & Holt, J. T. (2000). Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies. Breast Cancer Res 2, 28-31.
Park, M. A., Seok, Y. J., Jeong, G. & Lee, J. S. (2008). SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res 36, 263-83.
Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108.
75 Phillips, K. A., Jenkins, M. A., Lindeman, G. J., McLachlan, S. A., McKinley, J. M., Weideman, P. C., Hopper, J. L. & Friedlander, M. L. (2006). Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet 70, 198-206.
Pistello, M., Bonci, F., Flynn, J. N., Mazzetti, P., Isola, P., Zabogli, E., Camerini, V., Matteucci, D., Freer, G., Pelosi, P. & Bendinelli, M. (2006). AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens. J Virol 80, 8856-68.
Pistello, M., Moscardini, M., Mazzetti, P., Bonci, F., Zaccaro, L., Isola, P., Freer, G., Specter, S., Matteucci, D. & Bendinelli, M. (2002). Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization. Virology 298, 84-95.
Pistello, M., Vannucci, L., Ravani, A., Bonci, F., Chiuppesi, F., Del Santo, B., Freer, G. & Bendinelli, M. (2007). Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes. Genet Vaccines Ther 5, 8.
Poeschla, E. M., Wong-Staal, F. & Looney, D. J. (1998). Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4, 354-7. Preston, D. L., Ron, E., Tokuoka, S., Funamoto, S., Nishi, N., Soda, M., Mabuchi, K. & Kodama, K.
(2007). Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168, 1-64.
Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G. P., Wilson, J. M. & Batshaw, M. L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80, 148-58.
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van 't Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., Daly, M. B., Olopade, O. I. & Weber, B. L. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22, 1055-62.
Rice, J. C., Ozcelik, H., Maxeiner, P., Andrulis, I. & Futscher, B. W. (2000). Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21, 1761-5.
Richardson, C. & Jasin, M. (2000). Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405, 697-700.
Ricks, D. M., Kutner, R., Zhang, X. Y., Welsh, D. A. & Reiser, J. (2008). Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 17, 441-50.
Rodriquez, E. & Domchek, S. M. (2007). The prevention of hereditary breast cancer. Semin Oncol 34, 401-5.
Rollison, D. E., Brownson, R. C., Hathcock, H. L. & Newschaffer, C. J. (2008). Case-control study of tobacco smoke exposure and breast cancer risk in Delaware. BMC Cancer 8, 157. Russo, J. & Russo, I. H. (2006). The role of estrogen in the initiation of breast cancer. J Steroid
Biochem Mol Biol 102, 89-96.
Rutter, J. L., Wacholder, S., Chetrit, A., Lubin, F., Menczer, J., Ebbers, S., Tucker, M. A., Struewing, J. P. & Hartge, P. (2003). Gynecologic surgeries and risk of ovarian cancer
76 in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst 95, 1072-8.
Saenz, D. T. & Poeschla, E. M. (2004). FIV: from lentivirus to lentivector. J Gene Med 6 Suppl 1, S95-104.
Sauer, M. K. & Andrulis, I. L. (2005). Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer. J Med Genet 42, 633-8.
Sinn, P. L., Burnight, E. R., Hickey, M. A., Blissard, G. W. & McCray, P. B., Jr. (2005). Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 79, 12818-27.
Sinn, P. L., Hickey, M. A., Staber, P. D., Dylla, D. E., Jeffers, S. A., Davidson, B. L., Sanders, D. A. & McCray, P. B., Jr. (2003). Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77, 5902-10.
Sivaraman, L. & Medina, D. (2002). Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 7, 77-92.
Skibbens, R. V., Sie, C. & Eastman, L. (2008). Role of chromosome segregation genes in BRCA1-dependent lethality. Cell Cycle 7.
Szabo, C. I., Worley, T. & Monteiro, A. N. (2004). Understanding germ-line mutations in BRCA1. Cancer Biol Ther 3, 515-20.
Talbott, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. A. & Elder, J. H. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A 86, 5743-7.
Teng, L. S., Zheng, Y. & Wang, H. H. (2008). BRCA1/2 associated hereditary breast cancer. J Zhejiang Univ Sci B 9, 85-9.
Thomassen, M., Hansen, T. V., Borg, A., Lianee, H. T., Wikman, F., Pedersen, I. S., Bisgaard, M. L., Nielsen, F. C., Kruse, T. A. & Gerdes, A. M. (2008). BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncol 47, 772-7. Tomlinson, G. E., Chen, T. T., Stastny, V. A., Virmani, A. K., Spillman, M. A., Tonk, V., Blum, J. L.,
Schneider, N. R., Wistuba, II, Shay, J. W., Minna, J. D. & Gazdar, A. F. (1998). Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58, 3237-42.
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J. & Abraham, R. T. (2000). Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 14, 2989-3002.
Uyei, A., Peterson, S. K., Erlichman, J., Broglio, K., Yekell, S., Schmeler, K., Lu, K., Meric-Bernstam, F., Amos, C., Strong, L. & Arun, B. (2006). Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer 107, 2745-51.
Van Maele, B., De Rijck, J., De Clercq, E. & Debyser, Z. (2003). Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. J Virol 77, 4685-94.
77 Veronesi, A., de Giacomi, C., Magri, M. D., Lombardi, D., Zanetti, M., Scuderi, C., Dolcetti, R., Viel, A., Crivellari, D., Bidoli, E. & Boiocchi, M. (2005). Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases. BMC Cancer 5, 70.
Wang, G., Sinn, P. L., Zabner, J. & McCray, P. B., Jr. (2002). Gene transfer to airway epithelia using feline immunodeficiency virus-based lentivirus vectors. Methods Enzymol 346, 500-14.
Willett, B. J., Cannon, C. A. & Hosie, M. J. (2003). Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection. J Virol 77, 709-12.
Woodman, I. (2002). Breast feeding reduces risk of breast cancer, says study. Bmj 325, 184. Wright, J. F., Qu, G., Tang, C. & Sommer, J. M. (2003). Recombinant adeno-associated virus:
formulation challenges and strategies for a gene therapy vector. Curr Opin Drug Discov Devel 6, 174-8.
Wu, W., Koike, A., Takeshita, T. & Ohta, T. (2008). The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div 3, 1.
Wysocki, P. J., Grabarczyk, P. & Mackiewicz, A. (2001). Recent developments in retroviral gene delivery systems. Expert Opin Biol Ther 1, 911-3.
Xu, B., O'Donnell, A. H., Kim, S. T. & Kastan, M. B. (2002). Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 62, 4588-91.
Yankaskas, B. C. (2005). Epidemiology of breast cancer in young women. Breast Dis 23, 3-8. Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H. & Brody, L. C. (2002). BRCA1
regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30, 285-9.
Zhang, J. & Powell, S. N. (2005). The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 3, 531-9.
Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N. & Xia, F. (2004). Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 24, 708-18.
Zou, L. & Elledge, S. J. (2003). Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300, 1542-8.
Zufferey, R., Donello, J. E., Trono, D. & Hope, T. J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73, 2886-92.
